Latest On Amneal Pharmaceuticals, Inc (AMRX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-05 23:59 EST | News | Amneal Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call Presentation | N/A |  |
| 2023-05-05 23:59 EST | News | Amneal Pharmaceuticals, Inc. (AMRX) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-05 11:00 EST | News | Amneal Pharmaceuticals Non-GAAP EPS of $0.12 beats by $0.02, revenue of $558M beats by $15.82M | N/A | |
| 2023-05-04 22:14 EST | News | Amneal Pharmaceuticals Q1 2023 Earnings Preview | N/A | |
| 2023-04-17 18:46 EST | News | Amneal pops 3% after early look at Q1 results, re-affirms FY23 guidance | N/A | |
| 2023-03-10 04:46 EST | News | Gene therapy developer AskBio appoints ex Amneal commercial chief as CEO | N/A | |
| 2023-03-02 13:04 EST | News | Amneal Pharmaceuticals Non-GAAP EPS of $0.23 beats by $0.02, revenue of $610M beats by $30.07M | N/A | |
| 2023-03-02 13:04 EST | News | Amneal stock rises ~15% on FDA review of Narcan generic, Q4 beat | N/A | |
| 2023-03-02 13:03 EST | News | Amneal Pharmaceuticals, Inc. (AMRX) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-01 22:47 EST | News | Amneal Pharmaceuticals Q4 2022 Earnings Preview | N/A | |
| 2023-01-25 13:44 EST | News | Intercept Pharma gains after patent settlement with Amneal | N/A | |
| 2023-01-24 00:26 EST | News | Amneal Pharmaceuticals: Risk Still Persists | N/A | |
| 2023-01-15 19:42 EST | News | Drugmakers welcome new year with 450 drug price hikes so far | N/A | |
| 2023-01-11 19:58 EST | News | Amneal Pharmaceuticals (AMRX) presents at 41st Annual J.P. Morgan Healthcare Conference - Slideshow | N/A | |
| 2023-01-10 19:47 EST | News | Amneal Pharma reaffirms 2022 guidance | N/A | |
| 2023-01-04 16:19 EST | News | Amneal joins hands with Orion to commercialize generic products in Europe and more countries | N/A | |
| 2022-12-15 05:51 EST | News | Amneal Pharmaceuticals large shareholder TPG cuts stake | N/A | |
| 2022-11-12 00:59 EST | News | FDA accepts Amneal Pharmaceuticals NDA for Parkinson's drug IPX203 | N/A | |
| 2022-11-04 15:45 EST | News | Amneal Pharmaceuticals Non-GAAP EPS of $0.14 misses by $0.04, revenue of $545.56M misses by $16.61M | N/A | |
| 2022-11-04 15:45 EST | News | Amneal Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-04 15:44 EST | News | Amneal Pharmaceuticals, Inc. (AMRX) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-03 23:09 EST | News | Amneal Pharmaceuticals Q3 2022 Earnings Preview | N/A | |
| 2022-11-02 13:25 EST | News | AMD, JD and BILI are among pre market gainers | N/A | |
| 2022-11-02 13:25 EST | News | Amneal Pharma gets FDA nod for leuprolide acetate injection to treat prostate cancer | N/A | |
| 2022-10-28 12:24 EST | News | Amneal Pharmaceuticals: A Small 'Thumbs Up' | N/A | |
| 2022-09-01 01:51 EST | News | Amneal Pharma submits NDA for novel formulation of Parkinson's disease treatment | N/A | |
| 2022-08-06 06:05 EST | News | Amneal Pharmaceuticals, Inc. (AMRX) Management Team on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-05 14:38 EST | News | Amneal Pharmaceuticals Non-GAAP EPS of $0.19 in-line, revenue of $559M beats by $24.56M, revises FY earning guidance | N/A | |
| 2022-08-05 14:37 EST | News | Amneal shares lower after generic drugmaker cuts FY 2022 profit outlook | N/A | |
| 2022-08-04 23:18 EST | News | Amneal Pharmaceuticals Q2 2022 Earnings Preview | N/A | |
| 2022-06-01 11:05 EST | News | Amneal launches Lyvispah for muscle tightness due to spinal cord & neurological disorders | N/A | |
| 2022-05-27 16:22 EST | News | Amneal, Kashiv's biosimilar therapy to Amgen's Neulasta gets FDA approval | N/A | |
| 2022-05-04 22:47 EST | News | Amneal Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.01, revenue of $497.63M misses by $4.66M | N/A | |
| 2022-05-04 22:44 EST | News | Amneal falls 12% on disappointing Q1 result | N/A | |
| 2022-05-04 22:43 EST | News | Amneal Pharmaceuticals, Inc. (AMRX) Management Team on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-04 22:43 EST | News | Amneal Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-04 03:16 EST | News | Amneal Pharmaceuticals Q1 2022 Earnings Preview | N/A | |
| 2022-04-14 04:45 EST | News | Amneal Pharmaceuticals gets second U.S. biosimilar approval with FDA nod for Alymsys | N/A | |
| 2022-03-31 06:49 EST | News | Amneal Pharmaceuticals: Generics And Biosimilars Play Has Strong Upside Potential Under New / Old Management | N/A | |
| 2022-03-02 13:22 EST | News | Amneal Pharmaceuticals Non-GAAP EPS of $0.18 misses by $0.02, revenue of $537M beats by $3.59M | N/A | |
| 2022-03-02 13:21 EST | News | Amneal Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-03-02 13:21 EST | News | Amneal stock falls 8% following Q4 results; FY22 EPS outlook seen below estimates | N/A | |
| 2022-03-02 13:21 EST | News | Amneal Pharmaceuticals (AMRX) CEO, Chirag Patel on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-01 21:00 EST | News | Amneal Pharmaceuticals Q4 2021 Earnings Preview | N/A | |
| 2022-02-17 10:31 EST | News | Amneal gets FDA nod for 4 generic injectables products | N/A | |
| 2022-01-05 17:08 EST | News | Amneal acquires Saol Therapeutics’ Baclofen franchise for $83.5M | N/A | |
| 2021-12-22 12:19 EST | News | Revisiting Amneal Pharmaceuticals After Its CEO Buys Shares | N/A | |
| 2021-11-20 04:05 EST | News | Amneal receives ANDA approval for difluprednate ophthalmic emulsion | N/A | |
| 2021-11-04 03:51 EST | News | Amneal Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-11-04 03:51 EST | News | Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q3 2021 Results - Earnings Call Transcript | N/A | |
About Amneal Pharmaceuticals, Inc (AMRX):
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers licensed, owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinson's disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey.
General
- Name Amneal Pharmaceuticals, Inc
- Symbol AMRX
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 6,000
- Fiscal Year EndDecember
- IPO Date2009-01-15
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.amneal.com
View More
Valuation
- Trailing PE 11.33
- Forward PE 8.36
- Price/Sales (Trailing 12 Mt.) 0.45
- Price/Book (Most Recent Quarter) 2.93
- Enterprise Value Revenue 1.75
- Enterprise Value EBITDA 10.1
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $0.78
- Next Year EPS Estimate $0.87
- Next Quarter EPS Estimate $0.16
- Profit Margin 5%
- Operating Margin 7%
- Return on Assets 2%
- Return on Equity 20%
- Revenue 1.99 billion
- Earnings Per Share $0.61
- Revenue Per Share $13.51
- Gross Profit 652.32 million
- Quarterly Earnings Growth 28.4%
View More
Highlights
- Market Capitalization 1.02 billion
- EBITDA 381.05 million
- PE Ratio -15.35
- Analyst Target Price $6.1
- Book Value Per Share $2.05
View More
Share Statistics
- Shares Outstanding 147.7 million
- Shares Float 94.49 million
- % Held by Insiders 1043%
- % Held by Institutions 69.86%
- Shares Short 5.45 million
- Shares Short Prior Month 4.99 million
- Short Ratio 3.45
- Short % of Float 7%
- Short % of Shares Outstanding 4%
View More
Technicals
- Beta 1.29
- 52 Week High $7.32
- 52 Week Low $2.71
- 50 Day Moving Average 5.49
- 200 Day Moving Average 4.67
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Amneal Pharmaceuticals, Inc (AMRX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Amneal Pharmaceuticals, Inc (AMRX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-26 | $N/A | $0.14 | $0.13 | 5.42% |
| 2020-09-30 | 2020-11-06 | $N/A | $0.16 | $0.12 | 31.58% |
| 2020-06-30 | 2020-08-06 | $N/A | $0.13 | $0.10 | 34.85% |
| 2020-03-31 | 2020-05-11 | $498.53 million | $0.20 | $0.09 | 123.21% |
| 2019-12-31 | 2020-02-26 | $397.33 million | $0.08 | $0.05 | 56.56% |
| 2019-09-30 | 2019-11-06 | $378.28 million | $0.04 | $0.13 | -68.6% |
| 2019-06-30 | 2019-08-05 | $404.64 million | $0.09 | $0.12 | -27.18% |
| 2019-03-31 | 2019-05-09 | $446.12 million | $0.14 | $0.18 | -20.95% |
| 2018-12-31 | 2019-02-28 | $497.53 million | $0.33 | $0.27 | 21.01% |
| 2018-09-30 | 2018-11-07 | $476.49 million | $0.28 | $0.27 | 2.23% |
| 2018-06-30 | 2018-08-09 | $413.79 million | $0.24 | $0.22 | 7.33% |
| 2018-03-31 | 2018-05-11 | $275.19 million | $0.14 | $0.17 | -17.65% |
| 2017-12-31 | 2018-03-01 | $1.03 billion | $0.11 | $0.11 | 0% |
| 2017-09-30 | 2017-11-09 | $-107085000 | $0.23 | $0.20 | 15% |
| 2017-06-30 | 2017-08-09 | $478.56 million | $0.18 | $0.14 | 28.57% |
| 2017-03-31 | 2017-05-10 | $-371471000 | $0.11 | $0.13 | -15.38% |
| 2016-12-31 | 2017-03-01 | $298.58 million | $0.16 | $0.16 | 0% |
| 2016-09-30 | 2016-11-09 | $0.37 | $0.39 | -5.13% | |
| 2016-06-30 | 2016-08-09 | $0.21 | $0.32 | -34.38% | |
| 2016-03-31 | 2016-05-10 | $0.43 | $0.39 | 10.26% | |
| 2015-12-31 | 2016-02-22 | $0.62 | $0.44 | 40.91% | |
| 2015-09-30 | 2015-11-09 | $0.40 | $0.39 | 2.56% | |
| 2015-06-30 | 2015-08-10 | $0.34 | $0.35 | -2.86% | |
| 2015-03-31 | 2015-05-11 | $0.09 | $0.18 | -50% | |
| 2014-12-31 | 2015-02-24 | $0.16 | $0.12 | 33.33% | |
| 2014-09-30 | 2014-11-04 | $0.33 | $0.31 | 6.45% | |
| 2014-06-30 | 2014-08-06 | $0.60 | $0.36 | 66.67% | |
| 2014-03-31 | 2014-05-01 | $0.24 | $0.05 | 380% | |
| 2013-12-31 | 2014-02-20 | -$0.02 | $0.03 | -166.67% | |
| 2013-09-30 | 2013-11-04 | $0.25 | -$0.07 | 457.14% | |
| 2013-06-30 | 2013-08-08 | $0.23 | $0.04 | 475% | |
| 2013-03-31 | 2013-05-01 | $0.37 | $0.20 | 85% | |
| 2012-12-31 | 2013-02-25 | $0.30 | $0.19 | 57.89% | |
| 2012-09-30 | 2012-10-30 | $0.48 | $0.50 | -4% | |
| 2012-06-30 | 2012-07-31 | $0.60 | $0.45 | 33.33% | |
| 2012-03-31 | 2012-05-01 | $0.55 | $0.49 | 12.24% | |
| 2011-12-31 | 2012-02-28 | $0.36 | $0.22 | 63.64% | |
| 2011-09-30 | 2011-11-01 | $0.30 | $0.23 | 30.43% | |
| 2011-06-30 | 2011-08-02 | $0.22 | $0.19 | 15.79% | |
| 2011-03-31 | 2011-05-03 | $0.24 | $0.15 | 60% | |
| 2010-12-31 | 2011-02-24 | $0.23 | $0.22 | 4.55% | |
| 2010-09-30 | 2010-11-02 | $0.24 | $0.26 | -7.69% | |
| 2010-06-30 | 2010-08-03 | $0.48 | $0.51 | -5.88% | |
| 2010-03-31 | 2010-05-04 | $2.06 | $0.51 | 303.92% | |
| 2009-12-31 | 2010-02-25 | $0.69 | $0.14 | 392.86% | |
| 2009-09-30 | 2009-11-03 | $0.11 | $0.05 | 120% | |
| 2009-06-30 | 2009-08-04 | $0.05 | $0.03 | 66.67% | |
| 2004-09-30 | 2004-11-09 | $0.01 | $0.05 | -80% | |
| 2004-06-30 | 2004-08-04 | $0.01 | $0.03 | -66.67% | |
| 2004-03-31 | 2004-05-05 | $0.14 | -$0.03 | 566.67% | |
| 2003-12-31 | 2004-02-17 | -$0.05 | -$0.05 | 0% | |
| 2003-09-30 | 2003-11-05 | -$0.07 | -$0.02 | -250% | |
| 2003-06-30 | 2003-07-28 | -$0.05 | -$0.06 | 16.67% | |
| 2003-03-31 | 2003-04-30 | -$0.07 | -$0.08 | 12.5% | |
| 2002-12-31 | 2003-02-12 | -$0.07 | -$0.11 | 36.36% | |
| 2002-09-30 | 2002-10-28 | -$0.11 | -$0.13 | 15.38% | |
| 2002-06-30 | 2002-07-25 | -$0.13 | -$0.12 | -8.33% | |
| 2002-03-31 | 2002-04-30 | -$0.12 | -$0.13 | 7.69% | |
| 2001-12-31 | 2002-02-07 | -$0.15 | -$0.14 | -7.14% | |
| 2001-09-30 | 2001-10-30 | -$0.15 | -$0.14 | -7.14% | |
| 2001-06-30 | 2001-07-31 | -$0.15 | -$0.18 | 16.67% | |
| 2001-03-31 | 2001-05-02 | -$0.16 | -$0.21 | 23.81% | |
| 2000-12-31 | 2001-02-08 | -$0.20 | -$0.23 | 13.04% | |
| 2000-09-30 | 2000-10-31 | -$0.18 | -$0.21 | 14.29% | |
| 2000-06-30 | 2000-07-31 | -$0.21 | -$0.18 | -16.67% |
Amneal Pharmaceuticals, Inc (AMRX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Amneal Pharmaceuticals, Inc (AMRX) Chart:
Amneal Pharmaceuticals, Inc (AMRX) News:
Below you will find a list of latest news for Amneal Pharmaceuticals, Inc (AMRX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Amneal Pharmaceuticals, Inc (AMRX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-21 | 2.5 | 0 | CALL | 0 | 0 | 171.62 | TRUE | 0 | 0 |
| 2025-03-21 | 5 | 3.5 | CALL | 0 | 14 | 92.16 | TRUE | 0 | 0 |
| 2025-03-21 | 7.5 | 1.75 | CALL | 0 | 339 | 84.14 | TRUE | 0 | 0 |
| 2025-03-21 | 10 | 0.8 | CALL | 5 | 228 | 50.59 | FALSE | 0.8 | 0 |
| 2025-03-21 | 12.5 | 0.48 | CALL | 1 | 1 | 60.12 | FALSE | 0.48 | 0 |
| 2025-03-21 | 15 | 0.15 | CALL | 0 | 5 | 54.3 | FALSE | 0 | 0 |
| 2025-03-21 | 17.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 7.5 | 0.95 | PUT | 0 | 514 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 10 | 2.17 | PUT | 0 | 6 | 0 | TRUE | 0 | 0 |
| 2025-03-21 | 12.5 | 0 | PUT | 0 | 0 | 91.58 | TRUE | 0 | 0 |
| 2025-03-21 | 15 | 0 | PUT | 0 | 0 | 75.09 | TRUE | 0 | 0 |
| 2025-03-21 | 17.5 | 0 | PUT | 0 | 0 | 158.52 | TRUE | 0 | 0 |
Latest AMRX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $3.03 |
| Jun 13, 2022 7:59 PM EST | 100 | $3.03 |
| Jun 13, 2022 7:59 PM EST | 415 | $3.03 |
| Jun 13, 2022 7:59 PM EST | 200 | $3.03 |
| Jun 13, 2022 7:59 PM EST | 100 | $3.03 |
Amneal Pharmaceuticals, Inc (AMRX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000120919120030339/0001209191-20-030339-index.htm |
| 2018-11-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000008025518002959/0000080255-18-002959-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000008025519002754/0000080255-19-002754-index.htm |
| 2019-09-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000008025519002934/0000080255-19-002934-index.htm |
| 2019-12-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000008025519003018/0000080255-19-003018-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000021545719006845/0000215457-19-006845-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000031506619000863/0000315066-19-000863-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000031506620000784/0000315066-20-000784-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000083423720004817/0000834237-20-004817-index.htm |
| 2019-08-26 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1723128/000089843219001108/0000898432-19-001108-index.htm |
| 2019-08-26 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1723128/000089843219001109/0000898432-19-001109-index.htm |
| 2019-09-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1723128/000089843219001162/0000898432-19-001162-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006625/0000899243-20-006625-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006627/0000899243-20-006627-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006629/0000899243-20-006629-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006633/0000899243-20-006633-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006635/0000899243-20-006635-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006636/0000899243-20-006636-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006637/0000899243-20-006637-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006807/0000899243-20-006807-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006808/0000899243-20-006808-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006809/0000899243-20-006809-index.htm |
| 2020-03-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007819/0000899243-20-007819-index.htm |
| 2020-03-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007820/0000899243-20-007820-index.htm |
| 2020-03-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/0000899243-20-007821-index.htm |
| 2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007988/0000899243-20-007988-index.htm |
| 2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007990/0000899243-20-007990-index.htm |
| 2020-03-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320008424/0000899243-20-008424-index.htm |
| 2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320008429/0000899243-20-008429-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320009026/0000899243-20-009026-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012068/0000899243-20-012068-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012183/0000899243-20-012183-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012185/0000899243-20-012185-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012186/0000899243-20-012186-index.htm |
| 2020-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012187/0000899243-20-012187-index.htm |
| 2020-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012257/0000899243-20-012257-index.htm |
| 2020-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012259/0000899243-20-012259-index.htm |
| 2020-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012261/0000899243-20-012261-index.htm |
| 2020-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012265/0000899243-20-012265-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012444/0000899243-20-012444-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012451/0000899243-20-012451-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012452/0000899243-20-012452-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012453/0000899243-20-012453-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012466/0000899243-20-012466-index.htm |
| 2018-11-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000090221918000529/0000902219-18-000529-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000090221919000126/0000902219-19-000126-index.htm |
| 2020-01-28 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000090221920000328/0000902219-20-000328-index.htm |
| 2019-08-07 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1723128/000091412119002136/0000914121-19-002136-index.htm |
| 2019-08-07 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1723128/000091412119002138/0000914121-19-002138-index.htm |
| 2019-01-31 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000093247119002240/0000932471-19-002240-index.htm |
| 2019-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000093247119004732/0000932471-19-004732-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000110465920017627/0001104659-20-017627-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000110465920018499/0001104659-20-018499-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723128/000110465920020703/0001104659-20-020703-index.htm |
| 2019-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000114420419038060/0001144204-19-038060-index.htm |
| 2019-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000114420419038365/0001144204-19-038365-index.htm |
| 2018-11-13 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1723128/000119312518325599/0001193125-18-325599-index.htm |
| 2019-03-01 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000119312519059421/0001193125-19-059421-index.htm |
| 2019-03-01 | POSASR | Post-effective Amendment to an automatic shelf registration statement | https://www.sec.gov/Archives/edgar/data/1723128/000119312519059683/0001193125-19-059683-index.htm |
| 2019-03-01 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1723128/000119312519061022/0001193125-19-061022-index.htm |
| 2019-10-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000119312519266540/0001193125-19-266540-index.htm |
| 2019-10-11 | PRE 14C | Other preliminary information statements | https://www.sec.gov/Archives/edgar/data/1723128/000119312519266797/0001193125-19-266797-index.htm |
| 2019-10-21 | DEF 14C | Other definitive information statements | https://www.sec.gov/Archives/edgar/data/1723128/000119312519270854/0001193125-19-270854-index.htm |
| 2019-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000119312519310283/0001193125-19-310283-index.htm |
| 2019-12-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000119312519315267/0001193125-19-315267-index.htm |
| 2020-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000119312520007787/0001193125-20-007787-index.htm |
| 2020-02-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000119312520023178/0001193125-20-023178-index.htm |
| 2020-02-20 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000119312520043609/0001193125-20-043609-index.htm |
| 2020-02-20 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000119312520043613/0001193125-20-043613-index.htm |
| 2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000119312520050188/0001193125-20-050188-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000119312520071730/0001193125-20-071730-index.htm |
| 2020-04-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1723128/000119312520108170/0001193125-20-108170-index.htm |
| 2020-04-17 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000119312520110622/0001193125-20-110622-index.htm |
| 2020-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000119312520136972/0001193125-20-136972-index.htm |
| 2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000119312520209316/0001193125-20-209316-index.htm |
| 2020-08-17 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1723128/000119312520222437/0001193125-20-222437-index.htm |
| 2020-01-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000120919120002856/0001209191-20-002856-index.htm |
| 2020-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000120919120004719/0001209191-20-004719-index.htm |
| 2020-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000120919120009662/0001209191-20-009662-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000120919120029727/0001209191-20-029727-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000120919120030339/0001209191-20-030339-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000120919120044578/0001209191-20-044578-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000120919120044579/0001209191-20-044579-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000120919120044581/0001209191-20-044581-index.htm |
| 2019-03-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1723128/000130817919000058/0001308179-19-000058-index.htm |
| 2019-03-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1723128/000130817919000059/0001308179-19-000059-index.htm |
| 2020-03-23 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1723128/000130817920000070/0001308179-20-000070-index.htm |
| 2020-03-23 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1723128/000130817920000071/0001308179-20-000071-index.htm |
| 2019-07-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000138713119005208/0001387131-19-005208-index.htm |
| 2019-07-19 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1723128/000138713119005210/0001387131-19-005210-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000156459019040651/0001564590-19-040651-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1723128/000156459019041240/0001564590-19-041240-index.htm |
| 2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000156459020006564/0001564590-20-006564-index.htm |
| 2020-03-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1723128/000156459020008179/0001564590-20-008179-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000156459020023833/0001564590-20-023833-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1723128/000156459020024256/0001564590-20-024256-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000162828019013997/0001628280-19-013997-index.htm |
| 2018-12-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000172312818000039/0001723128-18-000039-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000005/0001723128-19-000005-index.htm |
| 2019-01-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000007/0001723128-19-000007-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000009/0001723128-19-000009-index.htm |
| 2019-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000011/0001723128-19-000011-index.htm |
| 2019-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000013/0001723128-19-000013-index.htm |
| 2019-01-23 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000015/0001723128-19-000015-index.htm |
| 2019-01-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000017/0001723128-19-000017-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000019/0001723128-19-000019-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000023/0001723128-19-000023-index.htm |
| 2019-03-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000028/0001723128-19-000028-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000033/0001723128-19-000033-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000034/0001723128-19-000034-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000035/0001723128-19-000035-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000036/0001723128-19-000036-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000038/0001723128-19-000038-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000040/0001723128-19-000040-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000042/0001723128-19-000042-index.htm |
| 2019-05-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000049/0001723128-19-000049-index.htm |
| 2019-05-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000050/0001723128-19-000050-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000064/0001723128-19-000064-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000065/0001723128-19-000065-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000066/0001723128-19-000066-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000067/0001723128-19-000067-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000068/0001723128-19-000068-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000069/0001723128-19-000069-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000070/0001723128-19-000070-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000071/0001723128-19-000071-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000072/0001723128-19-000072-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000073/0001723128-19-000073-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000074/0001723128-19-000074-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000076/0001723128-19-000076-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000079/0001723128-19-000079-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000081/0001723128-19-000081-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000087/0001723128-19-000087-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000088/0001723128-19-000088-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000089/0001723128-19-000089-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000090/0001723128-19-000090-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000091/0001723128-19-000091-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000094/0001723128-19-000094-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000095/0001723128-19-000095-index.htm |
| 2019-05-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000097/0001723128-19-000097-index.htm |
| 2019-07-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000100/0001723128-19-000100-index.htm |
| 2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000105/0001723128-19-000105-index.htm |
| 2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000107/0001723128-19-000107-index.htm |
| 2019-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000111/0001723128-19-000111-index.htm |
| 2019-08-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000112/0001723128-19-000112-index.htm |
| 2019-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000114/0001723128-19-000114-index.htm |
| 2019-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000116/0001723128-19-000116-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000118/0001723128-19-000118-index.htm |
| 2019-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000120/0001723128-19-000120-index.htm |
| 2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000127/0001723128-19-000127-index.htm |
| 2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000128/0001723128-19-000128-index.htm |
| 2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000129/0001723128-19-000129-index.htm |
| 2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000130/0001723128-19-000130-index.htm |
| 2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000131/0001723128-19-000131-index.htm |
| 2019-12-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000138/0001723128-19-000138-index.htm |
| 2019-12-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000139/0001723128-19-000139-index.htm |
| 2019-12-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000140/0001723128-19-000140-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000144/0001723128-19-000144-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000145/0001723128-19-000145-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000146/0001723128-19-000146-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1723128/000172312820000002/0001723128-20-000002-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000172312820000010/0001723128-20-000010-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1723128/000172312820000013/0001723128-20-000013-index.htm |
| 2020-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1723128/000172312820000023/0001723128-20-000023-index.htm |
| 2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1723128/000172312820000026/0001723128-20-000026-index.htm |
Amneal Pharmaceuticals, Inc (AMRX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amneal Pharmaceuticals, Inc (AMRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1043%Institutional Ownership: 6986%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-05-19 | John Kiely | Director | Buy | 10,000.00 | 4.40 | 44,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1723128/000120919120030339/0001209191-20-030339-index.htm |
| 2019-05-07 | Robert A Stewart | President and CEO | Buy | 83,277.00 | 100,277.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000088/0001723128-19-000088-index.htm | ||
| 2020-03-01 | ANDREW S BOYER | Exec VP, Comm Optns | Buy | 12,345.00 | 108,313.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006808/0000899243-20-006808-index.htm | ||
| 2020-05-07 | ANDREW S BOYER | Exec VP, Comm Optns | Buy | 16,656.00 | 118,286.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012466/0000899243-20-012466-index.htm | ||
| 2020-05-07 | Emily Peterson Alva | Director | Buy | 6,459.00 | 12,566.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012265/0000899243-20-012265-index.htm | ||
| 2020-03-17 | PAUL M MEISTER | Director | Buy | 149,439.00 | 2.79 | 416,934.81 | 149,439.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320009026/0000899243-20-009026-index.htm |
| 2020-03-03 | Gautam Patel | Director | Buy | 117,889.00 | 3.94 | 464,482.66 | 156,107.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007820/0000899243-20-007820-index.htm |
| 2020-05-07 | Gautam Patel | Director | Buy | 6,459.00 | 162,566.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012259/0000899243-20-012259-index.htm | ||
| 2019-08-05 | International Ltd Fosun | 10% Share Holder | Buy | 1,642,300.00 | 3.04 | 4,992,592.00 | 1,642,300.00 | https://www.sec.gov/Archives/edgar/data/1723128/000114420419038060/0001144204-19-038060-index.htm |
| 2019-03-12 | PAUL BISARO | Executive Chairman | Buy | 17,000.00 | 11.97 | 203,490.00 | 17,000.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000040/0001723128-19-000040-index.htm |
| 2019-03-12 | Robert A Stewart | President and CEO | Buy | 17,000.00 | 11.92 | 202,640.00 | 17,000.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000042/0001723128-19-000042-index.htm |
| 2019-05-07 | Nikita Shah | SVP, Chief HR Officer | Buy | 4,441.00 | 170,477.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000087/0001723128-19-000087-index.htm | ||
| 2019-05-08 | J KEVIN BUCHI | Director | Buy | 6,107.00 | 17,408.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000074/0001723128-19-000074-index.htm | ||
| 2020-03-01 | Nikita Shah | SVP, Chief HR Officer | Buy | 11,728.00 | 180,839.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006809/0000899243-20-006809-index.htm | ||
| 2020-05-07 | Nikita Shah | SVP, Chief HR Officer | Buy | 4,442.00 | 181,053.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012453/0000899243-20-012453-index.htm | ||
| 2019-05-08 | Janet S. Vergis | Director | Buy | 6,107.00 | 18,257.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000068/0001723128-19-000068-index.htm | ||
| 2019-05-07 | ANDREW S BOYER | Exec VP, Comm Optns | Buy | 16,655.00 | 18,655.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000090/0001723128-19-000090-index.htm | ||
| 2019-05-07 | Joseph Todisco | SVP, Specialty Commercial | Buy | 4,441.00 | 192,818.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000091/0001723128-19-000091-index.htm | ||
| 2020-03-03 | Chirag K. Patel | President, Co-CEO & Director | Buy | 156,421.00 | 3.88 | 606,913.48 | 197,169.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/0000899243-20-007821-index.htm |
| 2020-03-03 | Chintu Patel | Co-CEO and Director | Buy | 156,539.00 | 3.88 | 607,371.32 | 197,342.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007819/0000899243-20-007819-index.htm |
| 2020-01-22 | Todd P. Branning | SVP and CFO | Buy | 20,096.00 | 20,096.00 | https://www.sec.gov/Archives/edgar/data/1723128/000120919120004719/0001209191-20-004719-index.htm | ||
| 2019-05-13 | Joseph Todisco | SVP, Specialty Commercial | Buy | 15,000.00 | 9.88 | 148,200.00 | 205,590.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000094/0001723128-19-000094-index.htm |
| 2020-05-15 | Jeffrey P. George | Director | Buy | 23,810.00 | 4.16 | 99,049.60 | 23,810.00 | https://www.sec.gov/Archives/edgar/data/1723128/000120919120029727/0001209191-20-029727-index.htm |
| 2020-05-07 | J KEVIN BUCHI | Director | Buy | 6,459.00 | 23,867.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012257/0000899243-20-012257-index.htm | ||
| 2020-02-28 | Joseph Todisco | SVP, Specialty Commercial | Buy | 40,000.00 | 3.62 | 144,800.00 | 246,845.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006807/0000899243-20-006807-index.htm |
| 2019-03-06 | PETER R TERRERI | Director | Sell | 23,345.00 | 12.39 | 289,244.55 | 25,192.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000038/0001723128-19-000038-index.htm |
| 2020-03-04 | Chintu Patel | Co-CEO and Director | Buy | 58,765.00 | 3.97 | 233,297.05 | 256,107.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007819/0000899243-20-007819-index.htm |
| 2020-03-04 | Chirag K. Patel | President, Co-CEO & Director | Buy | 58,938.00 | 3.97 | 233,983.86 | 256,107.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/0000899243-20-007821-index.htm |
| 2020-05-07 | Joseph Todisco | SVP, Specialty Commercial | Buy | 4,442.00 | 256,236.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012452/0000899243-20-012452-index.htm | ||
| 2020-03-01 | Joseph Todisco | SVP, Specialty Commercial | Buy | 11,111.00 | 257,956.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320006807/0000899243-20-006807-index.htm | ||
| 2020-08-02 | PAUL M MEISTER | Director | Buy | 27,923.00 | 27,923.00 | https://www.sec.gov/Archives/edgar/data/1723128/000120919120044581/0001209191-20-044581-index.htm | ||
| 2020-01-03 | DAVID A BUCHEN | SVP, Chief Legal Officer | Buy | 27,614.00 | 28,614.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312820000002/0001723128-20-000002-index.htm | ||
| 2019-05-13 | ANDREW S BOYER | Exec VP, Comm Optns | Buy | 19,000.00 | 9.46 | 179,740.00 | 29,302.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000095/0001723128-19-000095-index.htm |
| 2019-08-06 | International Ltd Fosun | 10% Share Holder | Buy | 327,000.00 | 2.91 | 951,570.00 | 327,000.00 | https://www.sec.gov/Archives/edgar/data/1723128/000114420419038365/0001144204-19-038365-index.htm |
| 2020-03-18 | PAUL M MEISTER | Director | Buy | 204,210.00 | 2.71 | 553,409.10 | 353,649.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320009026/0000899243-20-009026-index.htm |
| 2020-03-10 | Chintu Patel | Co-CEO and Director | Buy | 100,000.00 | 3.09 | 309,000.00 | 356,107.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007990/0000899243-20-007990-index.htm |
| 2020-03-10 | Chirag K. Patel | President, Co-CEO & Director | Buy | 100,000.00 | 3.09 | 309,000.00 | 356,107.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007988/0000899243-20-007988-index.htm |
| 2020-05-07 | Chintu Patel | Co-CEO and Director | Buy | 6,459.00 | 362,566.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012444/0000899243-20-012444-index.htm | ||
| 2020-05-07 | Chirag K. Patel | President, Co-CEO & Director | Buy | 6,459.00 | 362,566.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012451/0000899243-20-012451-index.htm | ||
| 2019-08-16 | Pradeep Bhadauria | SVP, Chief Scientific Officer | Buy | 30,000.00 | 2.41 | 72,300.00 | 37,500.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000118/0001723128-19-000118-index.htm |
| 2020-03-02 | Gautam Patel | Director | Buy | 32,111.00 | 3.88 | 124,590.68 | 38,218.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007820/0000899243-20-007820-index.htm |
| 2020-03-02 | Chirag K. Patel | President, Co-CEO & Director | Buy | 34,641.00 | 3.87 | 134,060.67 | 40,748.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/0000899243-20-007821-index.htm |
| 2020-03-02 | Chintu Patel | Co-CEO and Director | Buy | 34,696.00 | 3.87 | 134,273.52 | 40,803.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320007819/0000899243-20-007819-index.htm |
| 2019-05-07 | PAUL BISARO | Executive Chairman | Buy | 24,983.00 | 41,983.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000089/0001723128-19-000089-index.htm | ||
| 2019-08-28 | Ted C Nark | Director | Buy | 50,000.00 | 2.39 | 119,500.00 | 56,107.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000120/0001723128-19-000120-index.htm |
| 2019-05-08 | Chintu Patel | Director | Buy | 6,107.00 | 6,107.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000072/0001723128-19-000072-index.htm | ||
| 2019-05-08 | Chirag K. Patel | Director | Buy | 6,107.00 | 6,107.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000065/0001723128-19-000065-index.htm | ||
| 2019-05-08 | Dharmendra Rama | Director | Buy | 6,107.00 | 6,107.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000071/0001723128-19-000071-index.htm | ||
| 2019-05-08 | Emily Peterson Alva | Director | Buy | 6,107.00 | 6,107.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000064/0001723128-19-000064-index.htm | ||
| 2019-05-08 | Gautam Patel | Director | Buy | 6,107.00 | 6,107.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000073/0001723128-19-000073-index.htm | ||
| 2019-05-08 | Jean Selden Greene | Director | Buy | 6,107.00 | 6,107.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000066/0001723128-19-000066-index.htm | ||
| 2019-05-08 | Ted C Nark | Director | Buy | 6,107.00 | 6,107.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000070/0001723128-19-000070-index.htm | ||
| 2020-05-07 | Ted C Nark | Director | Buy | 6,459.00 | 62,566.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012261/0000899243-20-012261-index.htm | ||
| 2019-03-06 | PETER R TERRERI | Director | Buy | 45,000.00 | 6.55 | 294,750.00 | 70,192.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000038/0001723128-19-000038-index.htm |
| 2019-05-15 | Pradeep Bhadauria | SVP, Chief Scientific Officer | Buy | 7,000.00 | 8.48 | 59,360.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000097/0001723128-19-000097-index.htm |
| 2019-05-08 | PETER R TERRERI | Director | Buy | 6,107.00 | 76,299.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000067/0001723128-19-000067-index.htm | ||
| 2020-05-04 | PETER R TERRERI | Director | Buy | 6,459.00 | 82,758.00 | https://www.sec.gov/Archives/edgar/data/1723128/000089924320012068/0000899243-20-012068-index.htm | ||
| 2019-01-15 | ROBERT L BURR | Director | Buy | 30,000.00 | 6.55 | 196,500.00 | 90,475.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000013/0001723128-19-000013-index.htm |
| 2019-08-07 | ANDREW S BOYER | Exec VP, Comm Optns | Buy | 66,666.00 | 2.89 | 192,664.74 | 95,968.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000116/0001723128-19-000116-index.htm |
| 2019-05-08 | ROBERT L BURR | Director | Buy | 6,107.00 | 96,582.00 | https://www.sec.gov/Archives/edgar/data/1723128/000172312819000069/0001723128-19-000069-index.htm |